Pages that link to "Q45934408"
Jump to navigation
Jump to search
The following pages link to Trends in the utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer: results from the National Cancer Database. (Q45934408):
Displaying 50 items.
- Risk based neoadjuvant chemotherapy in muscle invasive bladder cancer (Q26773664) (← links)
- Systemic therapy for bladder cancer finally comes into a new age. (Q30249047) (← links)
- Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review. (Q34993621) (← links)
- Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma (Q35731224) (← links)
- Increasing utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer in the United States (Q35748060) (← links)
- Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes (Q35866471) (← links)
- The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis. (Q36631959) (← links)
- Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer (Q36823607) (← links)
- Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study (Q37003991) (← links)
- Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings (Q37375315) (← links)
- Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact? (Q37530344) (← links)
- Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer (Q38226736) (← links)
- Treatment of muscle invasive bladder cancer in the elderly: navigating the trade-offs of risk and benefit (Q38615547) (← links)
- Chemotherapy for Muscle-Invasive Bladder Cancer. (Q38711504) (← links)
- Dose dense MVAC prior to radical cystectomy: a real-world experience (Q38720755) (← links)
- Improving Systemic Chemotherapy for Bladder Cancer (Q38777610) (← links)
- Neoadjuvant Chemotherapy in Elderly Patients With Bladder Cancer: Oncologic Outcomes From a Single Institution Experience. (Q38836370) (← links)
- Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer. (Q38983687) (← links)
- Current Concepts in the Management of Muscle Invasive Bladder Cancer (Q39105784) (← links)
- Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion (Q39165708) (← links)
- Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study (Q44761739) (← links)
- Bladder Cancer Recovery Pathways: A Systematic Review. (Q45934647) (← links)
- Impact of preoperative diagnostic TURBT on progression-free survival in patients with pathological high-grade, stage T3/T4 bladder urothelial carcinoma (Q47110089) (← links)
- Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer. (Q47758231) (← links)
- Increased Use of Cystectomy in Patients 75 and Older: A Contemporary Analysis of Survival and Perioperative Outcomes From the National Cancer Database (Q48038604) (← links)
- The effect of treatment at minority-serving hospitals on outcomes for bladder cancer. (Q49898366) (← links)
- Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy. (Q50225627) (← links)
- Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma. (Q52805267) (← links)
- Mind the gap: What is driving the survival disparity between the sexes in bladder cancer? (Q53762231) (← links)
- Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention. (Q55112901) (← links)
- Robotic radical cystectomy for the management of bladder cancer: Analysis of operative and pathological outcomes of eighteen patient. (Q55427608) (← links)
- Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience (Q57073248) (← links)
- Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma (Q57173909) (← links)
- Performance Measurement and Quality Improvement Initiatives for Bladder Cancer Care (Q57790957) (← links)
- A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease (Q58614974) (← links)
- Evaluating the role of neoadjuvant chemotherapy in bladder cancer patients with occult lymph node metastases (Q58804619) (← links)
- Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer (Q61808638) (← links)
- Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts (Q64260619) (← links)
- Modelling cost-effectiveness of a biomarker-based approach to neoadjuvant chemotherapy for muscle-invasive bladder cancer (Q88232447) (← links)
- Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma (Q88344199) (← links)
- Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy (Q88646235) (← links)
- Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era (Q89282318) (← links)
- Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy (Q90293717) (← links)
- Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival? (Q91000096) (← links)
- The impact of squamous histology on survival in patients with muscle-invasive bladder cancer (Q91296261) (← links)
- Role of gemcitabine and cisplatin as neoadjuvant chemotherapy in muscle invasive bladder cancer: Experience over the last decade (Q91813181) (← links)
- Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer (Q91933789) (← links)
- Overall survival is the primary endpoint in a trial of neoadjuvant chemotherapy for bladder cancer? (Q92247658) (← links)
- Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle-invasive bladder cancer (Q92438372) (← links)
- Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer (Q97527356) (← links)